Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00770926 · ClinicalTrials.gov registry record · NA
Reducing Disparities in Diabetes Risk Through Lifestyle Changes in Community Settings
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 230
- Enrollment target
NCT00770926 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 230 participants.
The verdict
NCT00770926, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
Study Summary
This study aims to design and test the effectiveness of a lifestyle diabetes risk reduction program, Live Well, Be Well, in reducing risk of diabetes in persons at risk with a focus on reaching lower-income, minority individuals.
Interventions
- BEHAVIORAL Live Well, Be Well
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2006-09 |
| Est. Completion | 2013-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00770926
The ClinicalTrials.gov registry entry for NCT00770926 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Live Well, Be Well is the first listed.
NCT00770926 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00770926 about?
NCT00770926 is a clinical study titled "Reducing Disparities in Diabetes Risk Through Lifestyle Changes in Community Settings". This study aims to design and test the effectiveness of a lifestyle diabetes risk reduction program, Live Well, Be Well, in reducing risk of diabetes in persons at risk with a focus on reaching lower-income, minority individuals.
What is the current status of trial NCT00770926?
This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2006-09. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00770926?
The interventions under investigation include: Live Well, Be Well (BEHAVIORAL).
Who is sponsoring clinical trial NCT00770926?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.